1. Hennawi, Marah, Pakasticali, Nagehan, Tashkandi, Hammad, Hussaini, Mohammad. 2022. Genomic Landscape of Mixed-Phenotype Acute Leukemia. In International journal of molecular sciences, 23, . doi:10.3390/ijms231911259. https://pubmed.ncbi.nlm.nih.gov/36232559/
2. Gaston, Daniel, Hansford, Samantha, Oliveira, Carla, Huntsman, David, Bedard, Karen. 2014. Germline mutations in MAP3K6 are associated with familial gastric cancer. In PLoS genetics, 10, e1004669. doi:10.1371/journal.pgen.1004669. https://pubmed.ncbi.nlm.nih.gov/25340522/
3. Weren, Robbert D A, van der Post, Rachel S, Vogelaar, Ingrid P, Hoogerbrugge, Nicoline, Ligtenberg, Marjolijn J L. 2018. Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility. In Journal of medical genetics, 55, 669-674. doi:10.1136/jmedgenet-2017-104962. https://pubmed.ncbi.nlm.nih.gov/29330337/
4. Ilinca, Andreea, Englund, Elisabet, Samuelsson, Sofie, Lindgren, Arne G, Puschmann, Andreas. 2021. MAP3K6 Mutations in a Neurovascular Disease Causing Stroke, Cognitive Impairment, and Tremor. In Neurology. Genetics, 7, e548. doi:10.1212/NXG.0000000000000548. https://pubmed.ncbi.nlm.nih.gov/33728376/
5. Petrovchich, Iva, Ford, James M. 2016. Genetic predisposition to gastric cancer. In Seminars in oncology, 43, 554-559. doi:10.1053/j.seminoncol.2016.08.006. https://pubmed.ncbi.nlm.nih.gov/27899187/
6. Matani, Hirsch, Sahu, Divya, Paskewicz, Michael, Zaidi, Ali H, Goel, Ajay. 2022. Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma. In Biomarker research, 10, 81. doi:10.1186/s40364-022-00429-6. https://pubmed.ncbi.nlm.nih.gov/36376989/
7. Kole, Christo, Charalampakis, Nikolaos, Sakellariou, Stratigoula, Papanikolaou, Ioannis S, Schizas, Dimitrios. 2022. Hereditary Diffuse Gastric Cancer: A 2022 Update. In Journal of personalized medicine, 12, . doi:10.3390/jpm12122032. https://pubmed.ncbi.nlm.nih.gov/36556253/
8. Eto, Nobuaki, Miyagishi, Makoto, Inagi, Reiko, Fujita, Toshiro, Nangaku, Masaomi. 2009. Mitogen-activated protein 3 kinase 6 mediates angiogenic and tumorigenic effects via vascular endothelial growth factor expression. In The American journal of pathology, 174, 1553-63. doi:10.2353/ajpath.2009.080190. https://pubmed.ncbi.nlm.nih.gov/19246638/
智鼠故事 
